ClinConnect ClinConnect Logo
Search / Trial NCT06940882

Development of a Novel Screening Tool for Anosognosia After Stroke.

Launched by UNIVERSITY OF EXETER · Apr 15, 2025

Trial Information

Current as of May 06, 2025

Not yet recruiting

Keywords

Anosognosia Stroke Assessment

ClinConnect Summary

This clinical trial is focused on developing a new tool to help identify anosognosia in patients who have had a stroke. Anosognosia is a condition where people are unaware of their own disabilities, which can make recovery difficult. By creating a reliable screening tool, the researchers hope to improve the care and rehabilitation of stroke patients, making it easier for healthcare professionals to understand their needs and provide appropriate support. The study will involve both stroke patients and the healthcare staff who work with them to see how well this new tool can be used in hospitals.

To participate in this trial, patients must be at least 18 years old and diagnosed with a stroke. Healthcare staff working in the stroke rehabilitation unit will also be involved. The trial will assess how acceptable and practical the new screening tool is for these professionals. While the study is not yet recruiting participants, its results could lead to better outcomes for stroke survivors and their families by ensuring they receive comprehensive care and support during their recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 years or above who are admitted to the stroke rehabilitation unit with a clinical diagnosis of stroke.
  • Multi-disciplinary staff working on the stroke rehabilitation unit.
  • Exclusion Criteria:
  • Patients with a clinical diagnosis other than stroke.

About University Of Exeter

The University of Exeter is a leading research institution in the United Kingdom, renowned for its commitment to advancing knowledge and innovation across various disciplines, including health and medicine. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The University of Exeter aims to translate scientific findings into practical applications that improve patient outcomes and inform public health strategies, fostering collaboration between researchers, healthcare professionals, and community stakeholders to address critical health challenges.

Locations

Patients applied

0 patients applied

Trial Officials

Alexis Clarke, DClinPsy, QiCN

Study Director

University of Exeter

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported